- Home
- FCO vs PMVP Comparison
FCO vs PMVP Comparison
Compare FCO & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCO
- PMVP
- Stock Information
- Founded
- FCO 1991
- PMVP 2013
- Country
- FCO United Kingdom
- PMVP United States
- Employees
- FCO N/A
- PMVP N/A
- Industry
- FCO Investment Managers
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- FCO Finance
- PMVP Health Care
- Exchange
- FCO Nasdaq
- PMVP Nasdaq
- Market Cap
- FCO 78.3M
- PMVP 71.9M
- IPO Year
- FCO N/A
- PMVP 2020
- Fundamental
- Price
- FCO $6.13
- PMVP $0.88
- Analyst Decision
- FCO
- PMVP Strong Buy
- Analyst Count
- FCO 0
- PMVP 2
- Target Price
- FCO N/A
- PMVP $5.50
- AVG Volume (30 Days)
- FCO 100.1K
- PMVP 165.3K
- Earning Date
- FCO 01-01-0001
- PMVP 05-12-2025
- Dividend Yield
- FCO 14.96%
- PMVP N/A
- EPS Growth
- FCO N/A
- PMVP N/A
- EPS
- FCO 0.43
- PMVP N/A
- Revenue
- FCO N/A
- PMVP N/A
- Revenue This Year
- FCO N/A
- PMVP N/A
- Revenue Next Year
- FCO N/A
- PMVP N/A
- P/E Ratio
- FCO $12.30
- PMVP N/A
- Revenue Growth
- FCO N/A
- PMVP N/A
- 52 Week Low
- FCO $4.73
- PMVP $0.82
- 52 Week High
- FCO $6.63
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- FCO 61.05
- PMVP 33.62
- Support Level
- FCO $5.96
- PMVP $0.85
- Resistance Level
- FCO $6.24
- PMVP $1.04
- Average True Range (ATR)
- FCO 0.13
- PMVP 0.06
- MACD
- FCO 0.04
- PMVP -0.01
- Stochastic Oscillator
- FCO 74.47
- PMVP 10.42
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.